| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 解热镇痛类原料药(元) | 3,120,198,136.24 | 1,877,968,283.62 | 3,171,564,382.95 | 1,497,165,394.76 |
| 医药中间体及其他(元) | 1,341,940,024.42 | 705,483,351.66 | 1,137,795,555.25 | 541,122,772.98 |
| 制剂(元) | 3,638,706,546.67 | 2,088,817,413.85 | 3,193,627,163.89 | 1,626,006,825.59 |
| 其他主营业务(元) | - | - | - | 1,626,006,825.59 |
| 营业成本(元) | ||||
| 解热镇痛类原料药(元) | - | 1,133,816,909.43 | 2,198,020,297.84 | 1,036,436,906.25 |
| 医药中间体及其他(元) | - | 658,269,666.12 | 975,611,216.35 | 441,008,903.39 |
| 制剂(元) | - | 1,488,959,678.66 | 2,292,024,592.96 | 1,234,081,647.26 |
| 其他主营业务(元) | - | - | - | 1,234,081,647.26 |
| 毛利(元) | ||||
| 解热镇痛类原料药(元) | - | 744,151,374.19 | 973,544,085.11 | 460,728,488.51 |
| 医药中间体及其他(元) | - | 47,213,685.54 | 162,184,338.90 | 100,113,869.59 |
| 制剂(元) | - | 599,857,735.19 | 901,602,570.93 | 391,925,178.33 |
| 其他主营业务(元) | - | - | - | 391,925,178.33 |
| 毛利率(%) | ||||
| 解热镇痛类原料药(%) | - | 39.63 | 30.70 | 30.77 |
| 医药中间体及其他(%) | - | 6.69 | 14.25 | 18.50 |
| 制剂(%) | - | 28.72 | 28.23 | 24.10 |
| 其他主营业务(%) | - | - | - | 24.10 |
| 收入构成(%) | ||||
| 解热镇痛类原料药(%) | 38.52 | 40.19 | 42.27 | 28.30 |
| 医药中间体及其他(%) | 16.57 | 15.10 | 15.16 | 10.23 |
| 制剂(%) | 44.92 | 44.71 | 42.56 | 30.74 |
| 其他主营业务(%) | - | - | - | 30.74 |
| 毛利构成(%) | ||||
| 解热镇痛类原料药(%) | - | 53.49 | 47.79 | 34.26 |
| 医药中间体及其他(%) | - | 3.39 | 7.96 | 7.45 |
| 制剂(%) | - | 43.12 | 44.25 | 29.15 |
| 其他主营业务(%) | - | - | - | 29.15 |